Ventyx Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€278.76K - Gross profit
-€278.76K - SG&A expenses
€25.71M - R&D expenses
€86.83M - EBITDA
-€111.69M - D&A
€1.12M - EBIT
-€112.54M - Interest expenses
€0.00 - EBT
-€102.72M - Tax expenses
€0.00 - Net income
-€102.72M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€6.55M - Changes in working capital
-€527.32K - Operating cash flow
-€91.23M - Capex
€55.23K - Other investing cash flow
€0.00 - Net investing cash flow
€60.29M - Total cash dividends paid
€0.00 - Issuance of common stock
-€200.22K - Debt repayment
€0.00 - Other financing cash flow
€23.16M - Net financing cash flow
€23.22M - Foreign exchange effects
€276.17K - Net change in cash
-€7.44M - Cash at end of period
€28.72M - Free cash flow
-€91.17M
Balance sheet
- Cash and cash equivalents
€27.88M - Cash and short-term investments
€180.34M - Total receivables
€863.04K - Inventory
€0.00 - Other current assets
€8.08M - Total current assets
€189.28M - Property, plant & equipment
€8.37M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€841.46K - Other non-current assets
€10.36K - Total non-current assets
€9.22M - Total assets
€198.51M - Accounts payable
€787.95K - Short-term debt
€982.14K - Other current liabilities
€8.13M - Total current liabilities
€9.90M - Long-term debt
€15.81M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€7.90M - Total liabilities
€17.80M - Common stock
€6.04K - Retained earnings
-€525.36M - Other equity
€214.03K - Total equity
€180.71M - Total liabilities and shareholders' equity
€198.51M
Company information
- Market capitalization
€142.03M - Employees
81 - Enterprise Value
€156.10M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-56.8% Much worse than peer group: -2.1% - ROA
-
-51.7% Worse than peer group: -40.1% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-64.3% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.27M